Key Events This Week
Jan 21: Stock hits upper circuit amid strong buying pressure
Jan 22: Another upper circuit hit with increased delivery volumes
Jan 23: Sharp decline to lower circuit amid heavy selling pressure
Week Close: Rs.9.35 (-0.43%) vs Sensex -3.31%

Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-23 13:00:14Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 23 Jan 2026, hitting its lower circuit limit and registering a maximum daily loss of 2.55%. The stock’s sharp decline reflects mounting investor concerns amid deteriorating technical and fundamental indicators.
Read full news article
Lasa Supergenerics Ltd Hits Upper Circuit Amid Strong Buying Pressure
2026-01-22 11:00:15Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in buying interest on 22 Jan 2026, hitting its upper circuit price limit. Despite recent underperformance relative to its sector and broader market indices, the stock’s sudden rally underscores intense demand and a potential shift in investor sentiment.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-01-22 10:10:41Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-14 11:00:08Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 14 Jan 2026, hitting its lower circuit limit amid intense selling pressure. The stock closed at ₹9.43, down 4.46% on the day, marking its fifth consecutive day of losses and signalling mounting investor concerns.
Read full news article
Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-12 13:00:24Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 12 Jan 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The share price plunged by nearly 5%, marking its maximum daily loss and signalling panic selling among investors amid subdued market sentiment.
Read full news articleLasa Supergenerics Ltd Falls 3.53%: 2 Key Events Shaping the Week
2026-01-10 13:01:27
Key Events This Week
5 Jan: Stock opens at Rs.10.92, down 3.62%
7 Jan: Hits upper circuit amid strong buying pressure
9 Jan: Hits lower circuit amid heavy selling pressure
9 Jan: Week closes at Rs.10.93, down 3.53%

Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-01-09 13:00:10Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 9 Jan 2026, hitting its lower circuit limit and registering a maximum daily loss of 4.8%. The stock’s sharp decline reflects mounting investor concerns amid falling participation and unfilled supply, signalling a period of heightened volatility and bearish sentiment.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-01-07 10:10:23Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 07 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15-Jan-2026 | Source : BSECertificate under Reg 74 (5) of SEBI (DP) Regulations 2018
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. January 02 2026 1. Appointment Of Mr. Ganesh Suresh Potdar As An Additional Director In Capacity Of (Executive Director) And Occupier Of All Units Of The Company.
02-Jan-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . January 02 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.
Closure of Trading Window
29-Dec-2025 | Source : BSEClosure of trading window for the quarter ended December 31 2025
Corporate Actions
No Upcoming Board Meetings
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available






